The malaria parasite multiplies in red blood cells, safe from our immune defences
Monkey tests hint compound could paralyse malaria parasite in humans.
A new-found chemical can root out malaria parasites hiding in red blood cells and stop them reproducing. It may become a much-needed new weapon in the war against one of the world’s biggest killers.
The compound clears monkeys of infection with the human malaria parasite Plasmodium falciparum at doses far lower than existing antimalarial drugs. But testing in humans is a few years away at least, says Henri Vial at Montpellier University in France who discovered the 1.
Vial’s team developed a range of compounds that interfere with the building of cell membranes. Rapidly reproducing parasites are constantly making new cell membranes.
They used infected human blood samples to screen all their chemicals for antimalarial activity. A compound with the working name G25 came out on top.
"We were very lucky," says Vial: G25 only enters red-blood cells that harbour reproducing malaria parasites. Why is a mystery, and "the focus of our research now", Vial says.
This selectivity is important for two reasons. First, because all animal cells make membranes, G25 would be highly toxic if it were less discerning. More importantly, scientists could exploit the chemical’s nose for malaria-infected cells to deliver other antimalarial compounds. "It is a natural targeting mechanism," Vial says.
"No other group of drugs works like this," says Peter Winstanley, who is developing new antimalarial drugs at the University of Liverpool in England. As a result, he hopes G25 could kill even drug-resistant malaria.
But because G25 acts on a fundamental biological system there could be harmful side-effects. Vial’s team saw nothing untoward in monkeys, but admits more work on the safety of the compound is needed.
Another big hurdle is getting the compound into pill form. Currently it has to be injected. "We do have problems with oral absorption," says Vial. Chemical tweaking of G25 should help.
Scientific obstacles aside, new malaria drugs face an uphill economic struggle, cautions Winstanley. To save the most lives, malaria drugs must be affordable for developing countries where the disease is endemic. Keeping development costs low enough to achieve this is hard.
The newest antimalarial drug on the market costs $57 for a course of treatment. For the developing world "it would need to cost a lot less than 50 cents", Winstanley says.
TOM CLARKE | © Nature News Service
Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania
The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration
"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...
Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.
Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
16.01.2017 | Power and Electrical Engineering
16.01.2017 | Information Technology
16.01.2017 | Power and Electrical Engineering